Investorideas.com breaking new for AI and tech stocks

Monday, November 4, 2019

The Benefits and Disadvantages of #AI - Are Computers Taking Over? @GbtTechnologies


The Benefits and Disadvantages of #AI - Are Computers Taking Over? @GbtTechnologies

November 4, 2019 (Investorideas.com Newswire) Lately, as new technologies emerge and eventually converse with each other, a growing awareness and concern has taken over tech developers and company chiefs since the fact that artificial intelligence is here to stay and there is no way of stopping it, or is there?

Let’s take a look at the good AI is bringing for us before we acknowledge what worries the tech community and perhaps the entire society.


Artificial Intelligence is outgrowing itself rapidly each day, from self-driving cars or autonomous super computers like Watson, they can make the best out of any task they are programmed to take care of. Created by humans to make things “faster, better, stronger” , artificial intelligence is about making building machines that can think and act intelligently, and learn from it.

At this moment, most applications are created and used for the benefit of mankind with tools such as transport, facial recognition, natural language processing or internet searches that make our lives easier and more secure every day. Soon AI will be authorized and able to operate in matters of law, jurisdiction, devices and programs will take care of your information, computer crashes, transactions, etc., all of it for the benefit of you and your loved ones. And that’s ok.

The impact that Amazon, Google, Recurrent.ai, Wai Yun AI, and Microsoft are making is rapidly accelerating the “AI race”. You see, the AI you’re aware of as a user every day is called “narrow AI”, this means that this kind of artificial intelligence, while autonomous and self-learning, is designed to take care of a specific task. Take for example Google’s search algorythms, they know what to look for and how to behave when they find it, just that.

General AI (AGI or strong AI) on the other side, is about outperforming humans at nearly every cognitive task.  An evolved AI, which is what most researches work on and want to achieve would have your car do exactly how you would do it, same with your pacemaker, airplane, your automatic trading system or your power grid.

The ultimate goal for Strong AI is to self-learn, is this bad?
The case of autonomous weapons is one to take a close look at. As with most technologies, AI will find itself increasingly used for military applications. A war, defense systems, or a battlefield filled with robots could become a dangerous reality if the machines go awry.

Who would take responsibility for an accident? Or much worse, a human life?
Many companies -including thousands of Google companies have pledged not to develop AI technologies for harmful use. Still, it is common knowledge that Amazon and Microsoft are doing so. There is pressure for another digital Vienna Convention to regulate, and agree on this matter. Technologists still claim that any AI they design and develop  is not authorized or capable of making “combat decisions” on its own, that it will always rely on a final decision made by a human. How sure can you be of this assumption when things like this happen:

Months ago, Facebook shut down its own robots after detecting that they might have developed their own language, and might be communicating fluently on their own. These two artificially intelligent programs appeared to be talking in a language only they understood.

The two Facebook chatbots created their own changes to the English language, this made it easier for them to communicate -though it remained a secret to the humans looking after them. Facebook was pushing for its robots to start a chat and negotiate towards a trade that included balls, hats and books. Each item was given a certain value, suddenly negotiations broke down as the robots appeared to me exchanging information, chanting at each other in a language incomprehensible to humans.

The developer’s flaw was not to specify the machines to use comprehensible English to negotiate between each other, which allowed them to create their own “shorthand” version.
After the negotiations in this language were decrypted, technologists found out that the trades had taken place effectively and that the conversations showed interest in a specific item. Researcher Mike Lewis justified shutting down the chats when he said "our interest was having bots who could talk to people".

Google was another one to reveal that the AI it uses for its Translate tool had created its own language, which it would translate things into and then out of. But the company was happy with that development and allowed it to continue.

A worried Elon Musk commented: "The pace of progress in artificial intelligence (I'm not referring to narrow AI) is incredibly fast. Unless you have direct exposure to groups like Deepmind, you have no idea how fast—it is growing at a pace close to exponential. The risk of something seriously dangerous happening in the five-year timeframe, 10 years at most.”

In order to exist AI has to be created by man; but if AI self-learns creation and assumes the autonomy to suggest and execute final decisions according to its own judgement, what happens next?

Perhaps this dog needs a leash.


About GBT TECHNOLOGIES, S.A
GBT Technologies, S.A., a private Costa Rican corporation (GBT -http://gbttechnologies.com) is a development-stage company in the business of the strategic management of BPO (Business Process Outsourcing) digital communications processing for enterprises and startups; distributed ledger technology development, AI development and fintech software development and applications. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Get more Technology stock investor ideas - news, articles, podcasts and stock directories





Breaking #Fintech #Stock Podcast Interview with CEO of Weyland Tech Inc. (OTCQX: $WEYL) Discussing Indonesia and Company’s Growth; @weylandtechinc


Breaking #Fintech #Stock Podcast Interview with CEO of Weyland Tech Inc. (OTCQX: $WEYL) Discussing Indonesia and Company’s Growth; @weylandtechinc 



Point Roberts WA, Delta BC – November 4, 2019 - Investorideas.com, a leading investor news resource covering fintech and mobile payment stocks releases an exclusive podcast interview  for investors following the sector.

Weyland Tech Inc (OTCQX:WEYL) is eyeing many opportunities and has already outperformed its 2018 revenue numbers, company CEO, Brent Suen stated in a recent interview with Investorideas.com.

Listen to the podcast









“For 2018 we had top line revenues of $22.6 million,” he said. “This year, in the first nine months of operations … based on our preliminary announcement … we’re already exceeding last year’s entire full-year numbers in the first nine months of this year. That is due to distribution partners, or what we call white label partnerships, who are seeing considerably higher growth from the additional functionality that we added in over this past nine months.”

Weyland, a developer and global provider of mobile business software applications, operates its CreateApp™ platform-as-a-service (PaaS) across three continents and 10 countries, including some of the fastest-growing emerging markets in Southeast Asia. Suen indicated that a top priority of the company is an uplisting, which would enhance the company’s profile and opportunities.

“The biggest one is the uplisting to Nasdaq, and that’s key to expanding a much higher level of visibility which in turn would enable, or certainly imply, a higher market cap,” he said. “And subsequently the ability to fund a more exponential expansion plan.”

“We believe that, upon gaining shareholder approval for management’s discretion on a reverse split, we will be able to exercise a modest reverse split and immediately qualify for Nasdaq,” he continued. “We expect that to happen before the end of the year. And we’re also, alongside that, evaluating merger and acquisition opportunities that would not only increase our scale, but would also increase the pipeline for products and services and also geographic expansion.”

Weyland typically enters markets with its CreateApp™ platform-as-a-service (PaaS) application, which allows micro and small businesses to design apps themselves, and market and promote their goods and services to their end customers much more affordably than having a third party designer.

“Our app, CreateApp™, enables the business owner to do a number of things, but the four primary ones are: a) to market and promote their goods and services, b) to enable them to sell online through the phone, c) to pay for them through the phone, and then d) have them delivered through logistics delivery or courier if it’s nearby.

What’s interesting about ours is that it can be created by our customer within one to two hours at a maximum, and that’s with zero technical skills,” he said. “It’s extremely important because most micro to small business owners … typically wouldn’t have the time, expertise or resources available to build their own app. So what we provide is a very simple and streamlined toolkit to do so. Further, [for] the app itself, what we price to our clients at an average of $20 to $25 per month. And that compared to having a native app custom built by a professional services firm is actually quite inexpensive.”

The company is taking a different approach to the Indonesian market, where roughly 70 percent of the population is unbanked, according to Suen, and therefore rely on alternatives such as e-wallets. Because of this, Weyland has entered the Indonesian market via its subsidiary, Weyland Indonesia Perkasa (WIP), and its ewallet Atozpay.

“When you don’t have bank accounts or credit cards … trying to sell things through the phone – e-commerce and m-commerce – is extraordinarily difficult to do in that type of environment,” he said. “So what has ended up happening is that the prevalence of mobile payments or e-wallets, of which Atozpay is, has gained tremendous traction in Indonesia.”

On the subject of Indonesia, with it being the fourth-most populous country in the world and boasting a growing confluence of big tech players and equity funds, Suen posits that it holds tremendous potential for investors.

“What I’ve found in the past two years of being back [in the U.S.], when I talk to potential investors … about Indonesia, most of the response, very naturally is, ‘that’s an entire world away’,” he said.

“There are currently over 15 tech companies based in Indonesia that have what are called unicorn valuations,” he said. “So, anything valued at a billion dollars or more would imply that it’s a Unicorn valuation. Several are actually higher than ten billion and this is notable because every major global tech giant has investments in these 15.”

“Not only are the big strategic tech companies making investments in these 15, we are also seeing the world’s leading private equity funds investing as well,” he added. “What you have is a landscape that’s a who’s who of global tech companies, a who’s who of private equity funds and venture capital funds, and what we’re going to see very soon is an impending wave of IPOs here in the US.”

Suen said that the company’s activities in Indonesia, coupled with its other developments, position it favorably for strategic investments or possibly acquisition.

“It puts us on the path for potential strategic investment in or an acquisition of, our Indonesian subsidiary by one of these larger companies,” he said. “What we believe will happen, is someone like Grab – which is currently a $16 billion valued company operating in Southeast Asia in its entirety – we believe that they will be a strategic investor in Weyland Indonesia Perkasa, or potentially acquire us.”

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns: Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining, the AI Eye .

Important Cautions Regarding Forward Looking Statements
This release contains certain “forward-looking statements” relating to the business of the Company. All statements, other than statements of historical fact included herein are “forward-looking statements” including statements regarding: the continued growth of the e-commerce segment and the ability of the Company to continue its expansion into that segment; the ability of the Company to attract customers and partners and generate revenues; the ability of the Company to successfully execute its business plan; the business strategy, plans, and objectives of the Company; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions and involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume any duty to update these forward-looking statements.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring WEYL is a paid for news release on Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800 665 0411


TechSectorStocks.com - investing ideas in tech stocks - mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)

Like Tech Stocks? View our 




Friday, November 1, 2019

The #AIEye: AWS (Nasdaq: $AMZN) Announces Infrastructure Region in Spain and MIT-IBM (NYSE: $IBM) #Watson Lab Research Reveals Impact of #AI Adoption on Jobs


The #AIEye: AWS (Nasdaq: $AMZN) Announces Infrastructure Region in Spain and MIT-IBM (NYSE: $IBM) #Watson Lab Research Reveals Impact of #AI Adoption on Jobs

AI in Healthcare to Reach $1.139 Billion by 2022



Point Roberts WA, Vancouver BC – November 1, 2019  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:



Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:AMZN) (NYSE:IBM)

Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), has announced the opening of an infrastructure region in Spain featuring three Availability Zones at launch. It will give Spanish startups, enterprises, and the public sector the ability to “leverage advanced technologies including analytics, artificial Intelligence, database, Internet of Things (IoT), machine learning, mobile services, serverless, and more to drive innovation”. Peter DeSantis, Vice President of Global Infrastructure and Customer Support, Amazon Web Services, commented:

“Cloud computing is already powering innovation within businesses, educational institutions, public administrations, and government agencies across Spain, and with this AWS infrastructure region, we look forward to helping accelerate this transformation. Opening an AWS Region in Spain will drive more technology jobs and businesses, boosting the local economy, while enabling organizations across all industries to lower costs, increase security, and improve agility. We’re excited to have AWS contribute to the future growth of Spain.”

IBM (NYSE:IBM) has released research from the MIT-IBM Watson AI Lab – which is described as “a collaborative industrial-academic laboratory focused on advancing fundamental AI research” – finding that AI will change the job landscape, but won’t actually eliminate many jobs. Martin Fleming, vice president and chief economist of IBM, commented:

"As new technologies continue to scale within businesses and across industries, it is our responsibility as innovators to understand not only the business process implications, but also the societal impact. To that end, this empirical research from the MIT-IBM Watson AI Lab sheds new light on how tasks are reorganizing between people and machines as a result of AI and new technologies."

The research finds that low-wage and high-wage occupations are actually experiencing increases in earnings as AI adoption progresses, whereas mid-wage jobs are the ones being “squeezed”.

AI in Healthcare to Reach $1.139 Billion by 2022

A report from Trends Market Research finds that the global AI in Healthcare market will reach $1.139 billion by 2022 with a compound annual growth rate (CAGR) of 62.2 percent in the forecast period 2016-2022. The following excerpt from the report description outlines the technology associated with the market:

The AI technology is leading towards innovation of efficient and inexpensive healthcare solutions. The major technologies involved are natural language processing, machine learning, biometric security, speech recognition and disaster recovery. The technology providers are heading towards development of innovative products and solutions for end-users. At present, NLP market is having the major share with an estimated increase to $487.7 million by 2022 growing at a CAGR of 61.6%. The increase in adoption of cloud computing, internet and innovation in network connectivity is driving the adoption of NLP in healthcare sector. Besides, NLP the second most prominent technology in healthcare is machine learning which is expected to reach $223.7 million by 2022, growing at a CAGR of 61.9%. Based on end users, the market encapsulates diagnostic centres, hospitals and clinics, R&D and healthcare institutes. AI finds wide application in precision medicine, real- time monitoring, drug development and personal health assistants.

Sam Mowers, Investorideas.com


For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800 665 0411

  



Get more tech stocks investor ideas- news, articles, podcasts  and stock directories



Investor Ideas adds New #Stocks in Cannabis (CSE: $MXT.C) (CSE: $PRMO.C), Biotech (Nasdaq: $IPHA, $VIR, $BNRX, $FREQ) and Tech (CSE: $AMPD.C) (CSE: $TKR.C)

Investor Ideas adds New #Stocks in Cannabis (CSE: $MXT.C) (CSE: $PRMO.C), Biotech (Nasdaq: $IPHA, $VIR, $BNRX, $FREQ) and Tech (CSE: $AMPD.C) (CSE: $TKR.C)




Point Roberts WA, Delta BC, November 1, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories in cannabis, biotech and tech.


This week’s new cannabis companies are both CSE-listed and are involved in COextraction and financing for the cannabis industry, respectively.

The latest biotech/life sciences companies are all October Nasdaq IPOs.

The newest tech companies are both CSE-listed and are involved in cloud computing and IoT & AI, respectively.

New Cannabis Companies:
MedXtractor Corp. (CSE:MXT) is a Calgary-based company that manufactures patented, proprietary small-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. At present, the Corporation targets the "Craft" cannabis grower. Craft growers are those whose crop is up to 800 indoor-sized plants per crop cycle. In management's opinion, CO2 Extractors represent the state-of-the-art for high-potency, high-purity oils, one of the fastest growing segments of the overall cannabis market. Cannabis oils can be extracted from flowers (bud), trim (leaves) and/or post-pressed rosin "chips" (leftovers from hydraulic press extraction). The ongoing worldwide legalization of cannabis is underpinning the rapidly growing demand for cannabis products with major growth seen in oils due to their utility as feedstock for various ingestion methods. The Corporation owns the patents on its CO2 Extractors.

Primo Nutraceuticals Inc. (CSE:PRMO) formerly Bougainville Ventures Inc - provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Cultivators lease these facilities and pay affordable fee-based management costs to accelerate market entry and scalability. The first 10,000 square feet of greenhouse space in Oroville, Washington has been completed and is ready for occupancy. Our facilities remove financial barriers for cannabis cultivators as traditional funding is limited due to United States federal laws and current lending practices.

New Biotech Companies:
INNATE PHARMA SA (NasdaqGS: IPHA) is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s commercial-stage product, Lumoxiti, in-licensed from AstraZeneca, was approved by the FDA in September 2018. Lumoxiti is a first-in class specialty oncology product for hairy cell leukemia (HCL). Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate Pharma has been a pioneer in the understanding of NK cell biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb, Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

VIR BIOTECHNOLOGY, INC(NasdaqGS:VIR) is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of five product candidates targeting hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis

BIONTECH SE (NasdaqGS:BNTX) was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. Its cutting-edge pipeline includes individualized mRNA-based product candidates, innovative chimeric antigen receptor T cells, novel checkpoint immunomodulators, targeted cancer antibodies and small molecules. BioNTech has established relationships with seven pharmaceutical collaborators, including Eli Lilly and Company, Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Genevant and Pfizer, and has published over 150 peer-reviewed publications on its scientific approach.

FREQUENCY THERAPEUTICS, INC(NasdaqGS:FREQ) is a leader in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The company’s progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. The company’s lead product candidate, FX-322, is designed to regenerate auditory hair cells to restore hearing function. In a FX-322 Phase 1/2 study, the company observed statistically significant and clinically meaningful improvement in key measures of hearing function in patients with sensorineural hearing loss. The company is evaluating additional diseases where its PCA approach could create functional tissue, including a development program in multiple sclerosis. Headquartered in Woburn, Mass., Frequency has a development and commercialization agreement with Astellas Pharma Inc. for FX-322, for which it retains U.S. rights, as well as additional collaboration agreements with academic and nonprofit research organizations including The Scripps Research Institute, Massachusetts Eye and Ear, and the Massachusetts Institute of Technology.

VIELA BIO, INC. (NasdaqGS:VIE) headquartered in Gaithersburg, Maryland, is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases.

APREA THERAPEUTICS, INC. (NasdaqGS:APRE) is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate  mutant tumor suppressor protein, p53. The Company’s lead product candidate is APR-246, a small molecule in clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

Neovasc, Inc. (TSX: NVCN.TONASDAQ: NVCN) is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and Tiara, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. 

New Tech Companies:
AMPD Ventures Inc. (CSE:AMPD) specializes in providing high-performance cloud and compute solutions for low-latency applications including video games and eSports, digital animation and visual effects, and big data collection, analysis and visualization.

Tracker Ventures Corp. (CSE:TKR) – formerly TrackLoop - is an analytics software company that is leveraging digital asset technology to transform and modernize multiple industries. TrackLoop is taking a diversified approach to the analytics and technology space, delivering practical solutions in the finance, logistics, cannabis, and pharmaceutical industries. The Company’s turnkey real-time tracking solutions offer the very latest in IoT and AI, providing valuable data and business intelligence to some of the world’s leading brands.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com
800-665-0411